Novo CEO pressed by Senate to cut prices of obesity, diabetes medicines CEO Lars Fruergaard Jørgensen informed lawmakers the corporation would take into consideration new talks with insurers about the list selling prices of Wegovy and copyright should they pledge to keep the medicines on their formularies. Insurers will continue https://johnathanwnfwp.thelateblog.com/31195498/5-easy-facts-about-healthcare-news-described